Open Access
Issue
J Extra Corpor Technol
Volume 55, Number 4, December 2023
Page(s) 189 - 193
DOI https://doi.org/10.1051/ject/2023034
Published online 15 December 2023
  1. Canter CE, Shaddy RE, Bernstein D, et al., Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;115(5):658–676. [CrossRef] [PubMed] [Google Scholar]
  2. Colvin M, Smith JM, Hadley N, et al. OPTN/SRTR 2018 annual data report: heart. Am J Transplant. 2020;20 Suppl s1:340–426. [CrossRef] [PubMed] [Google Scholar]
  3. Almond CSD, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009;119(5):717–727. [CrossRef] [PubMed] [Google Scholar]
  4. Mah D, Singh TP, Thiagarajan RR, et al. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009;28(12):1292–1298. [CrossRef] [PubMed] [Google Scholar]
  5. Leech SH, Lopez-Cepero M, LeFor WM, et al. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Clin Transplant. 2006;20(4):476–484. [CrossRef] [PubMed] [Google Scholar]
  6. Saadi TA, Lawrecki T, Narang N, et al. Outcomes of pre- heart transplantation desensitization in a series of highly sensitized patients bridged with left ventricular assist devices. J Heart Lung Transplant 2021;40(10):1107–1111. [CrossRef] [PubMed] [Google Scholar]
  7. Byku M, Chang PP. Desensitization for sensitized patients awaiting heart transplant. Curr Opin Organ Transplant. 2019;24(3):233–238. [CrossRef] [PubMed] [Google Scholar]
  8. Tambur AR, Pamboukian SV, Costanzo MR, et al., The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation. 2005;80(8):1019–1025. [CrossRef] [PubMed] [Google Scholar]
  9. West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med. 2001;344(11):793–800. [CrossRef] [PubMed] [Google Scholar]
  10. Foreman C, Gruenwald C, West L. ABO-incompatible heart transplantation: a perfusion strategy. Perfusion. 2004;19(1):69–72. [CrossRef] [PubMed] [Google Scholar]
  11. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544–2552. [CrossRef] [PubMed] [Google Scholar]
  12. Robertson A, Issitt R, Crook R, et al. A novel method for ABO-incompatible heart transplantation. J Heart Lung Transplant. 2018;37(4):451–457. [CrossRef] [PubMed] [Google Scholar]
  13. Grazioli A, Athale J, Tanaka K, et al. Perioperative applications of therapeutic plasma exchange in cardiac surgery: a narrative review. J Cardiothorac Vasc Anesth. 2020;34(12):3429–3443. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.